← 產業報告目錄

Veterinary Contract Manufacturing & Research Market by Service (Discovery, API Development, Regulatory Affairs, Consulting, Packaging & Labeling), Product (API, Fill-Finish, Medical Devices), Animal Type (Companion, Livestock) - Global Forecast to 2031

出版商 MarketsandMarkets產業別 Medical Devices出版日期 2026-02-19頁數 498報告編號 MD10278

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The veterinary contract manufacturing & research market is expected to grow from USD 6.38 billion in 2026 to USD 9.24 billion by 2031, at a CAGR of 7.7%. The market growth is driven by several key factors shaping the future of veterinary drug development, biologics manufacturing, and precision animal health. A major driver of this growth is the increasing demand for outsourced development and manufacturing services as animal health companies seek to accelerate product pipelines, reduce internal costs, and access specialized expertise for complex therapeutics such as biologics, vaccines, and advanced formulations. As the veterinary industry shifts toward more targeted, data-driven treatment approaches, the need for high-quality research, analytical testing, and GMP-compliant production is rapidly rising. Additionally, the growing burden of chronic, infectious, and zoonotic diseases in both companion and livestock animals is driving demand for faster and more efficient research and development (R&D) processes. CDMOs and CROs play a critical role in meeting this need by providing scalable manufacturing, high-throughput screening, and advanced study capabilities. The ongoing trend toward modernization in veterinary healthcare, including the adoption of real-time monitoring tools, digital workflows, and improved clinical trial management, further strengthens reliance on specialized outsourcing partners. Technological advancements, including the integration of AI for predictive modeling, automation in bioprocessing, and the development of enhanced analytical platforms, also drive market growth. These innovations enhance accuracy, shorten development timelines, and expand the applications of outsourced services across preclinical, clinical, and commercial phases. Overall, rising industry demands, advancements in technology, and the growing shift toward specialized and outsourced expertise are driving strong and sustained growth in the veterinary contract manufacturing & research market. “By animal type, the companion animals segment is projected to grow at the highest CAGR during the forecast period.” The software & services segment is expected to see the highest growth in the veterinary contract manufacturing & research market, due to rising pet ownership, increasing spending on advanced treatments, and growing demand for innovative therapeutics for dogs and cats. Conditions such as cancer, obesity, allergies, and chronic diseases are becoming more prevalent in pets, driving the need for new drugs, biologics, and specialty formulations. Pet owners’ willingness to invest in premium care, coupled with the humanization of pets and expanding insurance coverage, is encouraging animal health companies to develop more complex products—leading to greater outsourcing of R&D, manufacturing, and clinical studies to CDMOs and CROs.   “By end user, the multinational animal-health companies segment accounted for the largest market share in 2024.” In 2024, the veterinary clinics segment dominated the veterinary contract manufacturing & research market because they manage extensive product pipelines, operate globally regulated supply chains, and consistently invest in developing advanced therapeutics, vaccines, and diagnostics. Their broad portfolios and high production volumes create a strong need for specialized outsourcing partners to support formulation, scale-up, analytical testing, and clinical research. Additionally, these companies increasingly rely on CDMOs and CROs to accelerate time-to-market, expand manufacturing capacity, and access cutting-edge technologies, making them the primary contributors to overall market demand. “The Asia Pacific region is projected to witness the highest growth rate during the forecast period.” The Asia Pacific is expected to experience the highest growth in the veterinary contract manufacturing & research market, driven by rising livestock production, increasing pet ownership, and growing investment in animal health infrastructure across countries such as China, India, and Southeast Asia. The region is witnessing rapid expansion of veterinary pharmaceutical manufacturing, greater adoption of advanced biologics and diagnostics, and stronger government support for disease control and vaccination programs. Additionally, lower operational costs, improving regulatory frameworks, and the emergence of local CDMOs and CROs are attracting global animal health companies to outsource more research and manufacturing to APAC, driving its accelerated growth. Breakdown of supply-side primary interviews: • By Company Type: Tier 1 (60%), Tier 2 (30%), and Tier 3 (10%) • By Designation: C-level Executives (30%), Directors (50%), and Other Designations (20%) • By Region: North America (40%), Europe (25%), Asia Pacific (20%), Latin America (10%), and the Middle East & Africa (5%) Breakdown of demand-side primary interviews: • By End User: Multinational animal-health companies (59%), mid-sized / specialty animal-health firms (26%), and start-ups & veterinary biotech firms (15%) • By Designation: R&D directors/heads of research (47%), product development & innovation managers (22%), regulatory affairs managers/directors (15%), and others (16%) • By Region: North America (25%), Europe (24%), Asia Pacific (25%), Latin America (11%), and the Middle East & Africa (15%)   Research Coverage The market study covers the veterinary contract manufacturing & research market in various segments. It aims to estimate the market size and growth potential of this market by service, product type, animal type, end user, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their products and business offerings, recent developments, and key market strategies. Reasons to Buy the Report The report can help established companies and newer or smaller firms understand market trends, enabling them to capture a larger market share. Firms that acquire the report can implement one or more of the five strategies outlined below. This report provides insights into the following points: • Analysis of key drivers (growth in animal health spending, increasing complexity of veterinary biologics and the increasing regulatory burden for GMP, biosecurity & environmental compliance.), restraints (limited specialized infrastructure and long approval timelines & regulatory diversity globally), opportunities (geographic expansion into emerging markets, digital CRO services), and challenges (difficulty in clinical trial recruitment and difficulty in scaling sterile/biologics capacity quickly) influencing the growth of the veterinary contract manufacturing & research market • Product Development/Innovation: Detailed insights on upcoming technologies and service launches in the veterinary contract manufacturing & research market • Market Development: Comprehensive information about lucrative emerging markets; the report analyzes the markets for various types of veterinary CDMO & CRO services across regions • Market Diversification: Exhaustive information about services, untapped regions, recent developments, and investments in the veterinary contract manufacturing & research market • Competitive Assessment: In-depth assessment of market shares, strategies, services, distribution networks, and manufacturing capabilities of the leading players in the veterinary contract manufacturing & research market
目錄 Table of Contents
1 INTRODUCTION 44 1.1 STUDY OBJECTIVES 44 1.2 MARKET DEFINITION 44 1.3 STUDY SCOPE 45 1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE 45 1.3.2 INCLUSIONS & EXCLUSIONS 46 1.3.3 YEARS CONSIDERED 47 1.4 MARKET STAKEHOLDERS 47 1.5 LIMITATIONS 48 2 EXECUTIVE SUMMARY 49 3 PREMIUM INSIGHTS 56 3.1 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET OVERVIEW 56 3.2 ASIA PACIFIC: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE & COUNTRY (2025) 57 3.3 VETERINARY CROS MARKET: REGIONAL MIX 58 3.4 VETERINARY CDMOS MARKET: REGIONAL MIX 58 3.5 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 59 3.6 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET: DEVELOPED VS. EMERGING ECONOMIES 60 4 MARKET OVERVIEW 61 4.1 INTRODUCTION 61 4.2 MARKET DYNAMICS 61 4.2.1 DRIVERS 62 4.2.1.1 Growth in animal health spending 62 4.2.1.2 Increasing complexity of veterinary biologics 62 4.2.1.3 Rising regulatory requirements for GMP, biosecurity, and environmental compliance 63 4.2.2 RESTRAINTS 63 4.2.2.1 Limited specialized infrastructure 63 4.2.2.2 Long approval timelines & regulatory diversity globally 64 4.2.3 OPPORTUNITIES 65 4.2.3.1 Geographic expansion into emerging markets 65 4.2.3.2 Digital CRO services 65 4.2.4 CHALLENGES 66 4.2.4.1 Challenges in clinical trial recruitment 66 4.2.4.2 Difficulty in scaling sterile/biologics capacity quickly 66 4.3 UNMET NEEDS & WHITE SPACES 67 4.3.1 UNMET NEEDS IN VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET 67 4.3.2 WHITE SPACE OPPORTUNITIES 68 4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES 69 4.4.1 INTERCONNECTED MARKETS 69 4.4.2 CROSS-SECTOR OPPORTUNITIES 69 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 70 4.5.1 UNMET NEEDS IN VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET 70 5 INDUSTRY TRENDS 71 5.1 PORTER’S FIVE FORCES ANALYSIS 71 5.1.1 THREAT OF NEW ENTRANTS 72 5.1.2 THREAT OF SUBSTITUTES 73 5.1.3 BARGAINING POWER OF SUPPLIERS 73 5.1.4 BARGAINING POWER OF BUYERS 74 5.1.5 INTENSITY OF COMPETITIVE RIVALRY 74 5.2 MACROECONOMIC INDICATORS 75 5.2.1 INTRODUCTION 75 5.2.2 GDP TRENDS & FORECAST 75 5.2.3 TRENDS IN GLOBAL HEALTHCARE INDUSTRY 76 5.2.4 TRENDS IN GLOBAL MEDICAL DEVICE INDUSTRY 76 5.3 SUPPLY CHAIN ANALYSIS 77 5.4 VALUE CHAIN ANALYSIS 78 5.5 ECOSYSTEM ANALYSIS 79 5.6 PRICING ANALYSIS 80 5.6.1 AVERAGE SELLING PRICE TREND OF API & FILL-FINISH PHARMACEUTICALS & BIOLOGICS, BY KEY PLAYER, 2023–2025 81 5.6.2 AVERAGE SELLING PRICE TREND OF API & FILL-FINISH PHARMACEUTICALS & BIOLOGICS, BY REGION, 2023–2025 81 5.6.2.1 Average selling price trend of small-molecule pharmaceuticals for API/drug substance manufacturing, by region, 2023−2025 82 5.6.2.2 Average selling price trend of small-molecule pharmaceuticals for fill-finish/drug product manufacturing, by region, 2023−2025 82 5.6.2.3 Average selling price trend of animal health biologics & vaccines for API/drug substance manufacturing, by region, 2023−2025 82 5.6.2.4 Average selling price trend of animal health biologics & vaccines for fill-finish/drug product manufacturing, by region, 2023−2025 83 5.7 KEY CONFERENCES & EVENTS, 2026–2027 83 5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 84 5.9 INVESTMENT & FUNDING SCENARIO 85 5.10 SUCCESS STORIES & REAL-WORLD APPLICATIONS 86 5.10.1 END-TO-END CDMO SUPPORT FOR ANIMAL HEALTH LATERAL FLOW DIAGNOSTICS 86 5.10.2 END-TO-END CDMO SUPPORT FOR FIRST-IN-CLASS VETERINARY MONOCLONAL ANTIBODY (MAB) 87 5.10.3 END-TO-END BIOLOGICS OPTIMIZATION FOR CANINE ANTIBODY PROGRAMS 87 6 STRATEGIC DISRUPTIONS THROUGH TECHNOLOGY, PATENTS, AND DIGITAL & AI ADOPTION 88 6.1 TECHNOLOGY ANALYSIS 88 6.1.1 KEY EMERGING TECHNOLOGIES 88 6.1.1.1 High-throughput in vitro & in vivo screening platforms 88 6.1.1.2 AI/ML platforms for drug discovery 88 6.1.2 COMPLEMENTARY TECHNOLOGIES 89 6.1.2.1 Laboratory automation, robotics, and smart QC systems 89 6.1.2.2 Stability, cold chain, and packaging optimization technologies 89 6.1.3 ADJACENT TECHNOLOGIES 90 6.1.3.1 Digital therapeutics & software-as-a-medical-device (SaMD) 90 6.1.3.2 Precision livestock technologies 90 6.2 TECHNOLOGY/PRODUCT ROADMAP 91 6.2.1 NEAR TERM (2025–2027) 91 6.2.2 MID TERM (2028–2030) 91 6.2.3 LONG TERM (2030+) 91 6.3 PATENT ANALYSIS 92 6.3.1 PATENT PUBLICATION TRENDS FOR VETERINARY PHARMACEUTICALS 92 6.3.2 JURISDICTION & TOP APPLICANT ANALYSIS 93 6.4 FUTURE APPLICATIONS 95 6.4.1 ADVANCED BIOLOGICS & VACCINE MANUFACTURING PLATFORMS 95 6.4.2 DIGITALIZED, DATA-RICH CLINICAL DEVELOPMENT USING AI, REMOTE MONITORING, AND REAL-WORLD DATA 95 6.4.3 GLOBALIZED, REGULATORY-READY DEVELOPMENT WITH HARMONIZED QUALITY & MANUFACTURING SYSTEMS 95 6.4.4 INNOVATIVE FORMULATION TECHNOLOGIES FOR LONG-ACTING, SPECIES-TAILORED, AND DIFFICULT-TO-DELIVER PRODUCTS 96 6.5 IMPACT OF AI/GENERATIVE AI ON VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET 96 6.5.1 INTRODUCTION 96 6.5.2 MARKET POTENTIAL IN VETERINARY CONTRACT MANUFACTURING & RESEARCH ECOSYSTEM 96 6.5.3 AI USE CASES 97 6.5.4 KEY COMPANIES IMPLEMENTING AI IN VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET 97   7 SUSTAINABILITY & REGULATORY LANDSCAPE 99 7.1 REGIONAL REGULATIONS & COMPLIANCE 99 7.1.1 REGULATORY ANALYSIS 99 7.1.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 100 7.1.3 INDUSTRY STANDARDS 101 7.2 SUSTAINABILITY INITIATIVES 102 7.2.1 RECYCLED AND ECO-FRIENDLY MATERIALS FOR VETERINARY PRODUCTS 102 7.2.2 SUSTAINABILITY IMPACT & REGULATORY POLICY INITIATIVES 102 7.2.3 CERTIFICATIONS, LABELING, AND ECO-STANDARDS 102 8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 104 8.1 KEY STAKEHOLDERS & BUYING CRITERIA 104 8.1.1 KEY STAKEHOLDERS IN BUYING PROCESS 104 8.1.2 BUYING CRITERIA 105 8.2 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 106 8.2.1 DECISION-MAKING PROCESS 106 8.2.2 ADOPTION BARRIERS & INTERNAL CHALLENGES 107 8.2.3 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 107 8.2.4 MARKET PROFITABILITY 108 9 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE 109 9.1 INTRODUCTION 110 9.2 CRO SERVICES 112 9.2.1 DISCOVERY & PRE-CLINICAL STUDIES 115 9.2.1.1 Growing use of discovery & pre-clinical studies to accelerate veterinary drug pipeline initiation 115 9.2.2 VETERINARY CLINICAL TRIALS 117 9.2.2.1 Growing dependence on veterinary clinical trials to validate safety and efficacy for regulatory approvals to boost market 117 9.2.3 ANALYTICAL & BIOANALYTICAL SERVICES AND QUALITY ASSURANCE 119 9.2.3.1 Rising adoption of analytical & bioanalytical services to ensure high-quality, compliant veterinary products to fuel growth 119 9.2.4 REGULATORY AFFAIRS & CONSULTING 121 9.2.4.1 Increasing need for regulatory affairs & consulting to navigate complex global veterinary approval pathways to support growth 121 9.3 CDMO SERVICES 123 9.3.1 PROCESS API & FORMULATION DEVELOPMENT 126 9.3.1.1 Growing focus on process API & formulation development to optimize veterinary product performance to drive growth 126 9.3.2 MANUFACTURING 128 9.3.2.1 Increasing outsourcing of manufacturing to scale production of veterinary drugs and biologics 128 9.3.3 PACKAGING & LABELING 130 9.3.3.1 Rising dependence on packaging & labeling services to ensure regulatory-compliant product delivery to propel market 130 9.3.4 QUALITY/STABILITY & POST-MARKET SUPPORT 132 9.3.4.1 Expanding use of quality, stability, and post-market support to maintain lifecycle product compliance to boost market 132 10 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE 134 10.1 INTRODUCTION 135 10.2 MEDICINES 135 10.2.1 SMALL-MOLECULE PHARMACEUTICALS 138 10.2.1.1 API/Drug substance manufacturing 140 10.2.1.1.1 Growing focus on API manufacturing to support market growth 140 10.2.1.1.2 Global volume analysis of small-molecule pharmaceuticals market for API/drug substance manufacturing, by type, 2024–2031 (metric tons) 142 10.2.1.2 Fill-finish/drug product manufacturing 142 10.2.1.2.1 Increasing demand for fill-finish operations to fuel market growth 142 10.2.1.2.2 Global volume analysis of small-molecule pharmaceuticals market for fill-finish/drug product manufacturing, by type, 2024–2031 (ten thousand units) 144 10.2.2 ANIMAL HEALTH BIOLOGICS & VACCINES 144 10.2.2.1 API/Drug substance manufacturing 146 10.2.2.1.1 Rising demand for API/drug substance manufacturing to drive growth 146 10.2.2.1.2 Global volume analysis of animal health biologics & vaccines for API/drug substance manufacturing, by type, 2024–2031 (metric tons) 148 10.2.2.2 Fill-finish/drug product manufacturing 148 10.2.2.2.1 Rising dependence on fill-finish capabilities to fuel growth 148 10.2.2.2.2 Global volume analysis of animal health biologics & vaccines market for fill-finish/drug product manufacturing, by type, 2024–2031 (thousand units) 150 10.2.3 MEDICATED FEED & SUPPLEMENTS 150 10.2.3.1 Rising use of medicated feed & supplements to enhance livestock health and productivity 150 10.3 MEDICAL DEVICES 151 10.3.1 DIAGNOSTICS 154 10.3.1.1 Growing adoption of veterinary diagnostics to drive market growth 154 10.3.2 MONITORING SYSTEMS 156 10.3.2.1 Expanding utilization of monitoring systems to improve real-time animal health management to fuel growth 156   10.3.3 IMPLANTS 158 10.3.3.1 Increasing use of veterinary implants to support long-term treatment and orthopedic care to drive growth 158 11 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE 160 11.1 INTRODUCTION 161 11.2 COMPANION ANIMALS 161 11.2.1 DOGS 164 11.2.1.1 High adoption rates of dogs to drive market growth 164 11.2.2 CATS 166 11.2.2.1 Rising disease prevalence among cats to drive market 166 11.2.3 HORSES 168 11.2.3.1 Growing equine population to support market growth 168 11.2.4 OTHER COMPANION ANIMALS 170 11.3 LIVESTOCK ANIMALS 172 11.3.1 CATTLE 174 11.3.1.1 Growing consumption of meat to drive market 174 11.3.2 SWINE 176 11.3.2.1 Growing incidence of infectious diseases to drive market 176 11.3.3 POULTRY 178 11.3.3.1 Increasing demand for poultry meat to contribute to market growth 178 11.3.4 SHEEP & GOATS 180 11.3.4.1 Growing global demand for wool to drive market 180 11.3.5 OTHER LIVESTOCK ANIMALS 181 12 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER 183 12.1 INTRODUCTION 184 12.2 MULTINATIONAL ANIMAL HEALTH COMPANIES 184 12.2.1 INCREASED OUTSOURCING BY MULTINATIONAL ANIMAL HEALTH COMPANIES TO EXPAND GLOBAL PRODUCT DEVELOPMENT 184 12.3 MID-SIZED/SPECIALTY ANIMAL HEALTH FIRMS 186 12.3.1 RISING RELIANCE OF MID-SIZED & SPECIALTY ANIMAL HEALTH FIRMS ON CDMO/CRO PARTNERS TO BOOST PIPELINES 186 12.4 START-UPS & VETERINARY BIOTECH FIRMS 188 12.4.1 GROWING ENGAGEMENT OF START-UPS & VETERINARY BIOTECH FIRMS TO ACCESS ADVANCED DEVELOPMENT CAPABILITIES 188   13 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY REGION 190 13.1 INTRODUCTION 191 13.2 NORTH AMERICA 192 13.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 193 13.2.2 NORTH AMERICA: VOLUME ANALYSIS, BY PRODUCT TYPE, 2024–2031 193 13.2.3 NORTH AMERICA: VALUE ANALYSIS, 2024–2031 194 13.2.4 US 199 13.2.4.1 Rising pet population to drive demand 199 13.2.5 CANADA 204 13.2.5.1 Rising pet adoption rate to drive market 204 13.3 EUROPE 209 13.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 210 13.3.2 EUROPE: VOLUME ANALYSIS, BY PRODUCT TYPE, 2024–2031 211 13.3.3 EUROPE: VALUE ANALYSIS, 2024–2031 212 13.3.4 GERMANY 216 13.3.4.1 Germany to dominate European market during forecast period 216 13.3.5 UK 221 13.3.5.1 Increasing pet ownership to drive market growth 221 13.3.6 FRANCE 227 13.3.6.1 Rising cases of zoonotic diseases to drive market growth 227 13.3.7 ITALY 232 13.3.7.1 Growing livestock population to support market growth 232 13.3.8 SPAIN 237 13.3.8.1 Increasing animal healthcare expenditure to drive market growth 237 13.3.9 NETHERLANDS 242 13.3.9.1 Increasing companion animal population to drive market growth 242 13.3.10 REST OF EUROPE 247 13.4 ASIA PACIFIC 252 13.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 252 13.4.2 ASIA PACIFIC: VOLUME ANALYSIS, BY PRODUCT TYPE, 2024–2031 253 13.4.3 ASIA PACIFIC: VALUE ANALYSIS, 2024–2031 255 13.4.4 CHINA 259 13.4.4.1 China to dominate APAC market during forecast period 259 13.4.5 JAPAN 264 13.4.5.1 Aging pet population to drive market 264 13.4.6 INDIA 269 13.4.6.1 Rising livestock population to boost market growth 269 13.4.7 AUSTRALIA 275 13.4.7.1 Rising livestock animal population and increasing pet ownership to support market growth 275 13.4.8 SOUTH KOREA 280 13.4.8.1 Increasing demand for preventive care and aging pet population to drive market 280 13.4.9 THAILAND 285 13.4.9.1 Increasing demand for preventive care and aging pet population to drive market 285 13.4.10 NEW ZEALAND 290 13.4.10.1 High biosecurity standards to drive market 290 13.4.11 REST OF ASIA PACIFIC 295 13.5 LATIN AMERICA 299 13.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 299 13.5.2 LATIN AMERICA: VOLUME ANALYSIS, BY PRODUCT TYPE, 2024–2031 300 13.5.3 LATIN AMERICA: VALUE ANALYSIS, 2024–2031 301 13.5.4 BRAZIL 305 13.5.4.1 Brazil to dominate LATAM market due to rapidly increasing livestock population 305 13.5.5 MEXICO 310 13.5.5.1 Rising demand for animal-derived food products to contribute to market growth 310 13.5.6 ARGENTINA 315 13.5.6.1 Rising livestock population to fuel market growth 315 13.5.7 REST OF LATIN AMERICA 320 13.6 MIDDLE EAST & AFRICA 325 13.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 325 13.6.2 MIDDLE EAST & AFRICA: VOLUME ANALYSIS, BY PRODUCT TYPE, 2024–2031 326 13.6.3 MIDDLE EAST & AFRICA: VALUE ANALYSIS, 2024–2031 327 13.6.4 GCC COUNTRIES 331 13.6.4.1 Kingdom of Saudi Arabia (KSA) 336 13.6.4.1.1 Technological advancements & government initiatives to boost growth 336 13.6.4.2 United Arab Emirates (UAE) 341 13.6.4.2.1 Government support and high livestock population to fuel UAE's market growth 341 13.6.4.3 Rest of GCC Countries 346 13.6.5 REST OF MIDDLE EAST & AFRICA 350 14 COMPETITIVE LANDSCAPE 356 14.1 OVERVIEW 356 14.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 356 14.3 REVENUE ANALYSIS, 2021−2025 358 14.3.1 KEY VETERINARY CONTRACT RESEARCH ORGANIZATIONS 358 14.3.2 KEY VETERINARY CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS 358   14.4 VETERINARY CRO MARKET SHARE ANALYSIS, 2025 359 14.4.1 GLOBAL MARKET SHARE ANALYSIS OF VETERINARY CONTRACT RESEARCH ORGANIZATIONS, 2025 360 14.4.2 RANKING OF KEY MARKET PLAYERS 361 14.4.3 US MARKET SHARE ANALYSIS OF VETERINARY CONTRACT RESEARCH ORGANIZATIONS, 2025 362 14.4.4 EUROPE MARKET SHARE ANALYSIS OF VETERINARY CONTRACT RESEARCH ORGANIZATIONS, 2025 363 14.5 VETERINARY CDMO MARKET SHARE ANALYSIS, 2025 363 14.5.1 GLOBAL MARKET SHARE ANALYSIS OF VETERINARY CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS, 2025 364 14.5.2 RANKING OF KEY MARKET PLAYERS 365 14.5.3 US MARKET SHARE ANALYSIS OF VETERINARY CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS, 2025 366 14.5.4 EUROPE MARKET SHARE ANALYSIS OF VETERINARY CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS, 2025 367 14.6 COMPANY EVALUATION MATRIX: KEY VETERINARY CROS, 2025 367 14.6.1 STARS 367 14.6.2 EMERGING LEADERS 367 14.6.3 PERVASIVE PLAYERS 368 14.6.4 PARTICIPANTS 368 14.6.5 COMPANY FOOTPRINT: KEY VETERINARY CROS, 2025 369 14.6.5.1 Company footprint 369 14.6.5.2 Region footprint 369 14.6.5.3 Service footprint 370 14.6.5.4 Product type footprint 371 14.6.5.5 Animal type footprint 371 14.7 COMPANY EVALUATION MATRIX: VETERINARY CRO STARTUPS/SMES, 2025 372 14.7.1 PROGRESSIVE COMPANIES 372 14.7.2 RESPONSIVE COMPANIES 372 14.7.3 DYNAMIC COMPANIES 372 14.7.4 STARTING BLOCKS 372 14.7.5 COMPETITIVE BENCHMARKING: VETERINARY CRO STARTUPS/SMES, 2025 374 14.7.5.1 Detailed list of key veterinary CRO startups/SMEs 374 14.7.5.2 Competitive benchmarking of key veterinary CRO startups/SMEs 375 14.8 COMPANY EVALUATION MATRIX: VETERINARY CDMOS, 2025 375 14.8.1 STARS 376 14.8.2 EMERGING LEADERS 376 14.8.3 PERVASIVE PLAYERS 376 14.8.4 PARTICIPANTS 376 14.8.5 COMPANY FOOTPRINT: KEY VETERINARY CDMOS, 2025 378 14.8.5.1 Company footprint 378 14.8.5.2 Region footprint 378 14.8.5.3 Service footprint 379 14.8.5.4 Product type footprint 380 14.8.5.5 Animal type footprint 380 14.9 COMPANY EVALUATION MATRIX: VETERINARY CDMO STARTUPS/SMES, 2025 381 14.9.1 PROGRESSIVE COMPANIES 381 14.9.2 RESPONSIVE COMPANIES 381 14.9.3 DYNAMIC COMPANIES 381 14.9.4 STARTING BLOCKS 381 14.9.5 COMPETITIVE BENCHMARKING: VETERINARY CDMO STARTUPS/SMES, 2025 383 14.9.5.1 Detailed list of key veterinary CDMO startups/SMEs 383 14.9.5.2 Competitive benchmarking of key veterinary CDMO startups/SMEs 384 14.10 SERVICE COMPARATIVE ANALYSIS 385 14.11 COMPANY VALUATION & FINANCIAL METRICS 386 14.11.1 FINANCIAL METRICS 386 14.11.2 COMPANY VALUATION 386 14.12 COMPETITIVE SCENARIO 387 14.12.1 SERVICE LAUNCHES & APPROVALS 387 14.12.2 DEALS 388 14.12.3 EXPANSIONS 389 14.12.4 OTHER DEVELOPMENTS 390 15 COMPANY PROFILES 392 15.1 CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS 392 15.1.1 KEY PLAYERS 392 15.1.1.1 Argenta Holdco Limited 392 15.1.1.1.1 Business overview 392 15.1.1.1.2 Services offered 393 15.1.1.1.3 Recent developments 394 15.1.1.1.3.1 Service launches & upgrades 394 15.1.1.1.3.2 Deals 394 15.1.1.1.3.3 Expansions 395 15.1.1.1.4 MnM view 395 15.1.1.1.4.1 Key strengths 395 15.1.1.1.4.2 Strategic choices 395 15.1.1.1.4.3 Weaknesses & competitive threats 396 15.1.1.2 Aenova Group 397 15.1.1.2.1 Business overview 397 15.1.1.2.2 Services offered 398 15.1.1.2.3 Recent developments 399 15.1.1.2.3.1 Expansions 399 15.1.1.2.3.2 Other developments 401 15.1.1.2.4 MnM view 401 15.1.1.2.4.1 Key strengths 401 15.1.1.2.4.2 Strategic choices 401 15.1.1.2.4.3 Weaknesses & competitive threats 402 15.1.1.3 FAREVA SA 403 15.1.1.3.1 Business overview 403 15.1.1.3.2 Services offered 404 15.1.1.3.3 MnM view 405 15.1.1.3.3.1 Key strengths 405 15.1.1.3.3.2 Strategic choices 405 15.1.1.3.3.3 Weaknesses & competitive threats 405 15.1.1.4 Vetio 406 15.1.1.4.1 Business overview 406 15.1.1.4.2 Services offered 406 15.1.1.4.3 MnM view 408 15.1.1.4.3.1 Key strengths 408 15.1.1.4.3.2 Strategic choices 408 15.1.1.4.3.3 Weaknesses & competitive threats 408 15.1.1.5 TriRx Pharmaceutical Services 409 15.1.1.5.1 Business overview 409 15.1.1.5.2 Services offered 409 15.1.1.5.3 MnM view 410 15.1.1.5.3.1 Key strengths 410 15.1.1.5.3.2 Strategic choices 411 15.1.1.5.3.3 Weaknesses & competitive threats 411 15.1.1.6 Indian Immunologicals Ltd. 412 15.1.1.6.1 Business overview 412 15.1.1.6.2 Services offered 412 15.1.1.7 Recipharm AB 413 15.1.1.7.1 Business overview 413 15.1.1.7.2 Services offered 413 15.1.1.7.3 Recent developments 414 15.1.1.7.3.1 Technology launches 414 15.1.1.7.3.2 Deals 415 15.1.1.7.3.3 Expansions 415 15.1.1.7.3.4 Other developments 417 15.1.1.8 LABIANA 418 15.1.1.8.1 Business overview 418 15.1.1.8.2 Services offered 419 15.1.1.8.3 Recent developments 420 15.1.1.8.3.1 Other developments 420 15.1.1.9 Syngene International Limited 421 15.1.1.9.1 Business overview 421 15.1.1.9.2 Services offered 422 15.1.1.9.3 Recent developments 424 15.1.1.9.3.1 Deals 424 15.1.1.9.3.2 Other developments 425 15.1.1.10 CZ Vaccines 426 15.1.1.10.1 Business overview 426 15.1.1.10.2 Services offered 427 15.1.2 OTHER PLAYERS 428 15.1.2.1 AB7 Group 428 15.1.2.2 Kela Health 429 15.1.2.3 Eirgen Pharma 430 15.1.2.4 Bioingenium 431 15.1.2.5 Elise Biopharma 432 15.2 CONTRACT RESEARCH ORGANIZATIONS 433 15.2.1 KEY PLAYERS 433 15.2.1.1 Labcorp 433 15.2.1.1.1 Business overview 433 15.2.1.1.2 Services offered 434 15.2.1.1.3 Recent developments 435 15.2.1.1.3.1 Technology launches 435 15.2.1.1.3.2 Expansions 435 15.2.1.1.4 MnM view 436 15.2.1.1.4.1 Key strengths 436 15.2.1.1.4.2 Strategic choices 436 15.2.1.1.4.3 Weaknesses & competitive threats 436 15.2.1.2 Eurofins Scientific 437 15.2.1.2.1 Business overview 437 15.2.1.2.2 Services offered 438 15.2.1.2.3 Recent developments 439 15.2.1.2.3.1 Deals 439 15.2.1.2.4 MnM view 439 15.2.1.2.4.1 Key strengths 439 15.2.1.2.4.2 Strategic choices 440 15.2.1.2.4.3 Weaknesses & competitive threats 440 15.2.1.3 Charles River Laboratories 441 15.2.1.3.1 Business overview 441 15.2.1.3.2 Services offered 442 15.2.1.3.3 MnM view 443 15.2.1.3.3.1 Key strengths 443 15.2.1.3.3.2 Strategic choices 443 15.2.1.3.3.3 Weaknesses & competitive threats 444 15.2.1.4 Knoell Germany GmbH 445 15.2.1.4.1 Business overview 445 15.2.1.4.2 Services offered 445 15.2.1.4.3 Recent developments 447 15.2.1.4.3.1 Deals 447 15.2.1.4.4 Other developments 447 15.2.1.4.5 MnM view 447 15.2.1.4.5.1 Key strengths 447 15.2.1.4.5.2 Strategic choices 448 15.2.1.4.5.3 Weaknesses & competitive threats 448 15.2.1.5 Evotec 449 15.2.1.5.1 Business overview 449 15.2.1.5.2 Services offered 450 15.2.1.5.2.1 Deals 451 15.2.1.5.3 MnM view 451 15.2.1.5.3.1 Key strengths 451 15.2.1.5.3.2 Strategic choices 451 15.2.1.5.3.3 Weaknesses & competitive threats 452 15.2.1.6 KLIFOVET GmbH 453 15.2.1.6.1 Business overview 453 15.2.1.6.2 Services offered 454 15.2.1.7 Clinglobal 456 15.2.1.7.1 Business overview 456 15.2.1.7.2 Services offered 456 15.2.1.7.3 Recent developments 457 15.2.1.7.3.1 Service launches 457 15.2.1.7.3.2 Deals 458 15.2.1.7.3.3 Other developments 459 15.2.1.8 BioAgile Therapeutics Private Limited 460 15.2.1.8.1 Business overview 460 15.2.1.8.2 Services offered 460 15.2.1.9 Vetspin SRL 462 15.2.1.9.1 Business overview 462 15.2.1.9.2 Services offered 462 15.2.1.10 Veterinary Research Management 464 15.2.1.10.1 Business overview 464 15.2.1.10.2 Services offered 464 15.2.2 OTHER PLAYERS 466 15.2.2.1 Ridgeway Research Ltd. 466 15.2.2.2 Löhlein and Wolf Vet Research 467 15.2.2.3 Cebiphar 468 15.2.2.4 OCRvet 469 15.2.2.5 East Tennessee Clinical Research, Inc. 470   16 RESEARCH METHODOLOGY 471 16.1 RESEARCH DATA 471 16.2 RESEARCH METHODOLOGY DESIGN 471 16.2.1 SECONDARY DATA 471 16.2.1.1 Key data from secondary sources 472 16.2.2 PRIMARY DATA 473 16.2.2.1 Key data from primary sources 474 16.2.2.2 Key industry insights 475 16.3 MARKET SIZE ESTIMATION 477 16.3.1 BOTTOM-UP APPROACH 483 16.4 MARKET BREAKDOWN & DATA TRIANGULATION 485 16.5 MARKET SHARE ESTIMATION 486 16.5.1 RESEARCH ASSUMPTIONS 486 16.5.2 GROWTH RATE ASSUMPTIONS 486 16.6 RISK ASSESSMENT 487 16.7 RESEARCH LIMITATIONS 487 16.7.1 METHODOLOGY-RELATED LIMITATIONS 487 16.7.2 SCOPE-RELATED LIMITATIONS 487 17 APPENDIX 488 17.1 DISCUSSION GUIDE 488 17.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 493 17.3 CUSTOMIZATION OPTIONS 495 17.3.1 SERVICE ANALYSIS 495 17.3.2 COMPANY INFORMATION 495 17.3.3 GEOGRAPHIC ANALYSIS 495 17.3.4 REGIONAL/COUNTRY-LEVEL MARKET SHARE ANALYSIS 495 17.3.5 COUNTRY-LEVEL VOLUME ANALYSIS, BY PRODUCT TYPE 495 17.3.6 MARKET SHARE ANALYSIS, BY SERVICE (TOP 5 PLAYERS) 495 17.3.7 ANY CONSULT/CUSTOM REQUIREMENTS AS PER CLIENT REQUESTS 495 17.4 RELATED REPORTS 496 17.5 AUTHOR DETAILS 497
圖表清單 List of Tables & Figures
TABLE 1 STANDARD CURRENCY CONVERSION RATES (UNIT OF USD) 47 TABLE 2 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET: PORTER’S FIVE FORCES ANALYSIS 71 TABLE 3 GDP CHANGE, BY KEY COUNTRY, 2021–2030 (IN USD BILLION) 75 TABLE 4 AVERAGE SELLING PRICE TREND OF API & FILL-FINISH PHARMACEUTICALS & BIOLOGICS, BY KEY PLAYER, 2023–2025 81 TABLE 5 AVERAGE SELLING PRICE TREND OF SMALL-MOLECULE PHARMACEUTICALS FOR API/DRUG SUBSTANCE MANUFACTURING, BY REGION, 2023−2025 (USD PER KG) 82 TABLE 6 AVERAGE SELLING PRICE TREND OF SMALL-MOLECULE PHARMACEUTICALS FOR FILL-FINISH/DRUG PRODUCT MANUFACTURING, BY REGION, 2023−2025 (USD PER FINISHED UNIT) 82 TABLE 7 AVERAGE SELLING PRICE TREND OF ANIMAL HEALTH BIOLOGICS & VACCINES FOR API/DRUG SUBSTANCE MANUFACTURING, BY REGION, 2023−2025 (USD PER KG) 82 TABLE 8 AVERAGE SELLING PRICE TREND OF ANIMAL HEALTH BIOLOGICS & VACCINES FOR FILL-FINISH/DRUG PRODUCT MANUFACTURING, BY REGION, 2023−2025 (USD PER FINISHED UNIT) 83 TABLE 9 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET: MAJOR CONFERENCES & EVENTS IN 2026–2027 83 TABLE 10 CASE STUDY 1: END-TO-END CDMO SUPPORT FOR ANIMAL HEALTH LATERAL FLOW DIAGNOSTICS 86 TABLE 11 CASE STUDY 2: END-TO-END CDMO SUPPORT FOR FIRST-IN-CLASS VETERINARY MONOCLONAL ANTIBODY (MAB) 87 TABLE 12 CASE STUDY 3: END-TO-END BIOLOGICS OPTIMIZATION FOR CANINE ANTIBODY PROGRAMS 87 TABLE 13 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET: MAJOR PATENTS 93 TABLE 14 KEY COMPANIES IMPLEMENTING AI IN VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET 98 TABLE 15 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 100 TABLE 16 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 100 TABLE 17 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 101 TABLE 18 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VETERINARY CDMOS & CROS 104 TABLE 19 KEY BUYING CRITERIA FOR TOP THREE END USERS 106 TABLE 20 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024–2031 (USD MILLION) 110 TABLE 21 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 111 TABLE 22 KEY PLAYERS PROVIDING CRO SERVICES 112 TABLE 23 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 113 TABLE 24 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY COUNTRY, 2024–2031 (USD MILLION) 114 TABLE 25 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR DISCOVERY & PRE-CLINICAL STUDIES, BY COUNTRY, 2024–2031 (USD MILLION) 116 TABLE 26 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR VETERINARY CLINICAL TRIALS, BY COUNTRY, 2024–2031 (USD MILLION) 118 TABLE 27 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANALYTICAL & BIOANALYTICAL SERVICES AND QUALITY ASSURANCE, BY COUNTRY, 2024–2031 (USD MILLION) 120 TABLE 28 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR REGULATORY AFFAIRS & CONSULTING, BY COUNTRY, 2024–2031 (USD MILLION) 122 TABLE 29 KEY PLAYERS PROVIDING CDMO SERVICES 123 TABLE 30 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 124 TABLE 31 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY COUNTRY, 2024–2031 (USD MILLION) 125 TABLE 32 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR PROCESS API & FORMULATION DEVELOPMENT, BY COUNTRY, 2024–2031 (USD MILLION) 127 TABLE 33 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MANUFACTURING, BY COUNTRY, 2024–2031 (USD MILLION) 129 TABLE 34 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR PACKAGING & LABELING, BY COUNTRY, 2024–2031 (USD MILLION) 131 TABLE 35 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR QUALITY/STABILITY & POST-MARKET SUPPORT, BY COUNTRY, 2024–2031 (USD MILLION) 133 TABLE 36 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 135 TABLE 37 KEY PLAYERS PROVIDING VETERINARY MEDICINES 136 TABLE 38 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024–2031 (USD MILLION) 136 TABLE 39 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY COUNTRY, 2024–2031 (USD MILLION) 137 TABLE 40 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024–2031 (USD MILLION) 138 TABLE 41 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY COUNTRY, 2024–2031 (USD MILLION) 139 TABLE 42 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS IN API/DRUG SUBSTANCE MANUFACTURING, BY COUNTRY, 2024–2031 (USD MILLION) 141 TABLE 43 SMALL-MOLECULE PHARMACEUTICALS MARKET FOR API/DRUG SUBSTANCE MANUFACTURING, BY TYPE, 2024–2031 (METRIC TONS) 142 TABLE 44 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS IN FILL-FINISH/DRUG PRODUCT MANUFACTURING, BY COUNTRY, 2024–2031 (USD MILLION) 143 TABLE 45 SMALL-MOLECULE PHARMACEUTICALS MARKET FOR FILL-FINISH/DRUG PRODUCT MANUFACTURING, BY TYPE, 2024–2031 (TEN THOUSAND UNITS) 144 TABLE 46 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024–2031 (USD MILLION) 144 TABLE 47 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY COUNTRY, 2024–2031 (USD MILLION) 145 TABLE 48 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES IN API/DRUG SUBSTANCE MANUFACTURING, BY COUNTRY, 2024–2031 (USD MILLION) 147 TABLE 49 ANIMAL HEALTH BIOLOGICS & VACCINES MARKET FOR API/DRUG SUBSTANCE MANUFACTURING, BY TYPE, 2024–2031 (METRIC TONS) 148 TABLE 50 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES IN FILL-FINISH/DRUG PRODUCT MANUFACTURING, BY COUNTRY, 2024–2031 (USD MILLION) 149 TABLE 51 ANIMAL HEALTH BIOLOGICS & VACCINES MARKET FOR FILL-FINISH/DRUG PRODUCT MANUFACTURING, BY TYPE, 2024–2031 (THOUSAND UNITS) 150 TABLE 52 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICATED FEED & SUPPLEMENTS, BY COUNTRY, 2024–2031 (USD MILLION) 151 TABLE 53 KEY PLAYERS PROVIDING VETERINARY MEDICAL DEVICES 152 TABLE 54 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION) 152 TABLE 55 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY COUNTRY, 2024–2031 (USD MILLION) 153 TABLE 56 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR DIAGNOSTICS, BY COUNTRY, 2024–2031 (USD MILLION) 155 TABLE 57 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MONITORING SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 157 TABLE 58 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR IMPLANTS, BY COUNTRY, 2024–2031 (USD MILLION) 159 TABLE 59 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 161 TABLE 60 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 162 TABLE 61 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY COUNTRY, 2024–2031 (USD MILLION) 163 TABLE 62 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR DOGS, BY COUNTRY, 2024–2031 (USD MILLION) 165 TABLE 63 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CATS, BY COUNTRY, 2024–2031 (USD MILLION) 167 TABLE 64 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR HORSES, BY COUNTRY, 2024–2031 (USD MILLION) 169 TABLE 65 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR OTHER COMPANION ANIMALS, BY COUNTRY, 2024–2031 (USD MILLION) 171 TABLE 66 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 172 TABLE 67 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY COUNTRY, 2024–2031 (USD MILLION) 173 TABLE 68 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CATTLE, BY COUNTRY, 2024–2031 (USD MILLION) 175 TABLE 69 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SWINE, BY COUNTRY, 2024–2031 (USD MILLION) 177 TABLE 70 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR POULTRY, BY COUNTRY, 2024–2031 (USD MILLION) 179 TABLE 71 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SHEEP & GOATS, BY COUNTRY, 2024–2031 (USD MILLION) 181 TABLE 72 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR OTHER LIVESTOCK ANIMALS, BY COUNTRY, 2024–2031 (USD MILLION) 182 TABLE 73 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024–2031 (USD MILLION) 184 TABLE 74 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MULTINATIONAL ANIMAL HEALTH COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 185 TABLE 75 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MID-SIZED/SPECIALTY ANIMAL HEALTH FIRMS, BY COUNTRY, 2024–2031 (USD MILLION) 187 TABLE 76 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR START-UPS & VETERINARY BIOTECH FIRMS, BY COUNTRY, 2024–2031 (USD MILLION) 189 TABLE 77 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY REGION, 2024–2031 (USD MILLION) 192 TABLE 78 NORTH AMERICA: SMALL-MOLECULE PHARMACEUTICALS MARKET FOR API/DRUG SUBSTANCES, BY TYPE, 2024–2031 (METRIC TONS) 193 TABLE 79 NORTH AMERICA: SMALL-MOLECULE PHARMACEUTICALS MARKET FOR FILL-FINISH/DRUG PRODUCTS, BY TYPE, 2024–2031 (TEN THOUSAND UNITS) 193 TABLE 80 NORTH AMERICA: ANIMAL HEALTH BIOLOGICS & VACCINES MARKET FOR API/DRUG SUBSTANCES, BY TYPE, 2024–2031 (METRIC TONS) 194 TABLE 81 NORTH AMERICA: ANIMAL HEALTH BIOLOGICS & VACCINES MARKET FOR FILL-FINISH/DRUG PRODUCTS, BY TYPE, 2024–2031 (THOUSAND UNITS) 194 TABLE 82 NORTH AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET BY COUNTRY, 2024–2031 (USD MILLION) 194 TABLE 83 NORTH AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024–2031 (USD MILLION) 195 TABLE 84 NORTH AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 195 TABLE 85 NORTH AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 195 TABLE 86 NORTH AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 196 TABLE 87 NORTH AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024–2031 (USD MILLION) 196 TABLE 88 NORTH AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024–2031 (USD MILLION) 196 TABLE 89 NORTH AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024–2031 (USD MILLION) 197 TABLE 90 NORTH AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION) 197 TABLE 91 NORTH AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 197 TABLE 92 NORTH AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 198 TABLE 93 NORTH AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 198 TABLE 94 NORTH AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024–2031 (USD MILLION) 199 TABLE 95 US: KEY MACROINDICATORS 200 TABLE 96 US: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024–2031 (USD MILLION) 200 TABLE 97 US: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 200 TABLE 98 US: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 201 TABLE 99 US: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 201 TABLE 100 US: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024–2031 (USD MILLION) 201 TABLE 101 US: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024–2031 (USD MILLION) 202 TABLE 102 US: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024–2031 (USD MILLION) 202 TABLE 103 US: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION) 202 TABLE 104 US: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 203 TABLE 105 US: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 203 TABLE 106 US: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 203 TABLE 107 US: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024–2031 (USD MILLION) 204 TABLE 108 CANADA: KEY MACROINDICATORS 205 TABLE 109 CANADA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024–2031 (USD MILLION) 205 TABLE 110 CANADA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 205 TABLE 111 CANADA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 206 TABLE 112 CANADA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 206 TABLE 113 CANADA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024–2031 (USD MILLION) 206 TABLE 114 CANADA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024–2031 (USD MILLION) 207 TABLE 115 CANADA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024–2031 (USD MILLION) 207 TABLE 116 CANADA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION) 207 TABLE 117 CANADA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 208 TABLE 118 CANADA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 208 TABLE 119 CANADA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 208 TABLE 120 CANADA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024–2031 (USD MILLION) 209 TABLE 121 EUROPE: SMALL-MOLECULE PHARMACEUTICALS MARKET FOR API/DRUG SUBSTANCES, BY TYPE, 2024–2031 (METRIC TONS) 211 TABLE 122 EUROPE: SMALL-MOLECULE PHARMACEUTICALS MARKET FOR FILL-FINISH/DRUG PRODUCTS, BY TYPE, 2024–2031 (TEN THOUSAND UNITS) 211 TABLE 123 EUROPE: ANIMAL HEALTH BIOLOGICS & VACCINES MARKET FOR API/DRUG SUBSTANCES, BY TYPE, 2024–2031 (METRIC TONS) 211 TABLE 124 EUROPE: ANIMAL HEALTH BIOLOGICS & VACCINES MARKET FOR FILL-FINISH/DRUG PRODUCTS, BY TYPE, 2024–2031 (THOUSAND UNITS) 212 TABLE 125 EUROPE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 212 TABLE 126 EUROPE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024–2031 (USD MILLION) 212 TABLE 127 EUROPE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 213 TABLE 128 EUROPE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 213 TABLE 129 EUROPE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 213 TABLE 130 EUROPE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024–2031 (USD MILLION) 214 TABLE 131 EUROPE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024–2031 (USD MILLION) 214 TABLE 132 EUROPE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024–2031 (USD MILLION) 214 TABLE 133 EUROPE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION) 215 TABLE 134 EUROPE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 215 TABLE 135 EUROPE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 215 TABLE 136 EUROPE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 216 TABLE 137 EUROPE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024–2031 (USD MILLION) 216 TABLE 138 GERMANY: KEY MACROINDICATORS 217 TABLE 139 GERMANY: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024–2031 (USD MILLION) 217 TABLE 140 GERMANY: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 218 TABLE 141 GERMANY: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 218 TABLE 142 GERMANY: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 218 TABLE 143 GERMANY: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024–2031 (USD MILLION) 219 TABLE 144 GERMANY: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024–2031 (USD MILLION) 219 TABLE 145 GERMANY: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024–2031 (USD MILLION) 219 TABLE 146 GERMANY: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION) 220 TABLE 147 GERMANY: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 220 TABLE 148 GERMANY: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 220 TABLE 149 GERMANY: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 221 TABLE 150 GERMANY: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024–2031 (USD MILLION) 221 TABLE 151 UK: KEY MACROINDICATORS 222 TABLE 152 UK: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024–2031 (USD MILLION) 223 TABLE 153 UK: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 223 TABLE 154 UK: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 223 TABLE 155 UK: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 224 TABLE 156 UK: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024–2031 (USD MILLION) 224 TABLE 157 UK: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024–2031 (USD MILLION) 224 TABLE 158 UK: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024–2031 (USD MILLION) 225 TABLE 159 UK: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION) 225 TABLE 160 UK: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 225 TABLE 161 UK: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 226 TABLE 162 UK: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 226 TABLE 163 UK: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024–2031 (USD MILLION) 226 TABLE 164 FRANCE: KEY MACROINDICATORS 227 TABLE 165 FRANCE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024–2031 (USD MILLION) 228 TABLE 166 FRANCE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 228 TABLE 167 FRANCE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 228 TABLE 168 FRANCE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 229 TABLE 169 FRANCE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024–2031 (USD MILLION) 229 TABLE 170 FRANCE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024–2031 (USD MILLION) 229 TABLE 171 FRANCE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024–2031 (USD MILLION) 230 TABLE 172 FRANCE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION) 230 TABLE 173 FRANCE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 230 TABLE 174 FRANCE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 231 TABLE 175 FRANCE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 231 TABLE 176 FRANCE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024–2031 (USD MILLION) 231 TABLE 177 ITALY: KEY MACROINDICATORS 232 TABLE 178 ITALY: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024–2031 (USD MILLION) 233 TABLE 179 ITALY: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 233 TABLE 180 ITALY: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 233 TABLE 181 ITALY: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 234 TABLE 182 ITALY: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024–2031 (USD MILLION) 234 TABLE 183 ITALY: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024–2031 (USD MILLION) 234 TABLE 184 ITALY: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024–2031 (USD MILLION) 235 TABLE 185 ITALY: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION) 235 TABLE 186 ITALY: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 235 TABLE 187 ITALY: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 236 TABLE 188 ITALY: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 236 TABLE 189 ITALY: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024–2031 (USD MILLION) 236 TABLE 190 SPAIN: KEY MACROINDICATORS 237 TABLE 191 SPAIN: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024–2031 (USD MILLION) 238 TABLE 192 SPAIN: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 238 TABLE 193 SPAIN: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 238 TABLE 194 SPAIN: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 239 TABLE 195 SPAIN: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024–2031 (USD MILLION) 239 TABLE 196 SPAIN: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024–2031 (USD MILLION) 239 TABLE 197 SPAIN: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024–2031 (USD MILLION) 240 TABLE 198 SPAIN: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION) 240 TABLE 199 SPAIN: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 240 TABLE 200 SPAIN: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 241 TABLE 201 SPAIN: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 241 TABLE 202 SPAIN: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024–2031 (USD MILLION) 242 TABLE 203 NETHERLANDS: KEY MACROINDICATORS 243 TABLE 204 NETHERLANDS: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024–2031 (USD MILLION) 243 TABLE 205 NETHERLANDS: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 243 TABLE 206 NETHERLANDS: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 244 TABLE 207 NETHERLANDS: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 244 TABLE 208 NETHERLANDS: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024–2031 (USD MILLION) 244 TABLE 209 NETHERLANDS: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024–2031 (USD MILLION) 245 TABLE 210 NETHERLANDS: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024–2031 (USD MILLION) 245 TABLE 211 NETHERLANDS: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION) 245 TABLE 212 NETHERLANDS: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 246 TABLE 213 NETHERLANDS: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 246 TABLE 214 NETHERLANDS: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 246 TABLE 215 NETHERLANDS: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024–2031 (USD MILLION) 247 TABLE 216 REST OF EUROPE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024–2031 (USD MILLION) 248 TABLE 217 REST OF EUROPE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 248 TABLE 218 REST OF EUROPE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 248 TABLE 219 REST OF EUROPE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 249 TABLE 220 REST OF EUROPE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024–2031 (USD MILLION) 249 TABLE 221 REST OF EUROPE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024–2031 (USD MILLION) 249 TABLE 222 REST OF EUROPE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024–2031 (USD MILLION) 250 TABLE 223 REST OF EUROPE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION) 250 TABLE 224 REST OF EUROPE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 250 TABLE 225 REST OF EUROPE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 251 TABLE 226 REST OF EUROPE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 251 TABLE 227 REST OF EUROPE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024–2031 (USD MILLION) 251 TABLE 228 ASIA PACIFIC: SMALL-MOLECULE PHARMACEUTICALS MARKET FOR API/DRUG SUBSTANCES, BY TYPE, 2024–2031 (METRIC TONS) 253 TABLE 229 ASIA PACIFIC: SMALL-MOLECULE PHARMACEUTICALS MARKET FOR FILL-FINISH/DRUG PRODUCTS, BY TYPE, 2024–2031 (TEN THOUSAND UNITS) 254 TABLE 230 ASIA PACIFIC: ANIMAL HEALTH BIOLOGICS & VACCINES MARKET FOR API/DRUG SUBSTANCES, BY TYPE, 2024–2031 (METRIC TONS) 254 TABLE 231 ASIA PACIFIC: ANIMAL HEALTH BIOLOGICS & VACCINES MARKET FOR FILL-FINISH/DRUG PRODUCTS, BY TYPE, 2024–2031 (THOUSAND UNITS) 254 TABLE 232 ASIA PACIFIC: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 255 TABLE 233 ASIA PACIFIC: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024–2031 (USD MILLION) 255 TABLE 234 ASIA PACIFIC: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 256 TABLE 235 ASIA PACIFIC: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 256 TABLE 236 ASIA PACIFIC: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 256 TABLE 237 ASIA PACIFIC: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024–2031 (USD MILLION) 257 TABLE 238 ASIA PACIFIC: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024–2031 (USD MILLION) 257 TABLE 239 ASIA PACIFIC: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024–2031 (USD MILLION) 257 TABLE 240 ASIA PACIFIC: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION) 258 TABLE 241 ASIA PACIFIC: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 258 TABLE 242 ASIA PACIFIC: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 258 TABLE 243 ASIA PACIFIC: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 259 TABLE 244 ASIA PACIFIC: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024–2031 (USD MILLION) 259 TABLE 245 CHINA: KEY MACROINDICATORS 260 TABLE 246 CHINA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024–2031 (USD MILLION) 260 TABLE 247 CHINA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 261 TABLE 248 CHINA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 261 TABLE 249 CHINA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 261 TABLE 250 CHINA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024–2031 (USD MILLION) 262 TABLE 251 CHINA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024–2031 (USD MILLION) 262 TABLE 252 CHINA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024–2031 (USD MILLION) 262 TABLE 253 CHINA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION) 263 TABLE 254 CHINA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 263 TABLE 255 CHINA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 263 TABLE 256 CHINA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 264 TABLE 257 CHINA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024–2031 (USD MILLION) 264 TABLE 258 JAPAN: KEY MACROINDICATORS 265 TABLE 259 JAPAN: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024–2031 (USD MILLION) 265 TABLE 260 JAPAN: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 266 TABLE 261 JAPAN: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 266 TABLE 262 JAPAN: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 266 TABLE 263 JAPAN: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024–2031 (USD MILLION) 267 TABLE 264 JAPAN: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024–2031 (USD MILLION) 267 TABLE 265 JAPAN: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024–2031 (USD MILLION) 267 TABLE 266 JAPAN: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION) 268 TABLE 267 JAPAN: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 268 TABLE 268 JAPAN: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 268 TABLE 269 JAPAN: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 269 TABLE 270 JAPAN: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024–2031 (USD MILLION) 269 TABLE 271 INDIA: KEY MACROINDICATORS 270 TABLE 272 INDIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024–2031 (USD MILLION) 271 TABLE 273 INDIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 271 TABLE 274 INDIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 271 TABLE 275 INDIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 272 TABLE 276 INDIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024–2031 (USD MILLION) 272 TABLE 277 INDIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024–2031 (USD MILLION) 272 TABLE 278 INDIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024–2031 (USD MILLION) 273 TABLE 279 INDIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION) 273 TABLE 280 INDIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 273 TABLE 281 INDIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 274 TABLE 282 INDIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 274 TABLE 283 INDIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024–2031 (USD MILLION) 274 TABLE 284 AUSTRALIA: KEY MACROINDICATORS 275 TABLE 285 AUSTRALIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024–2031 (USD MILLION) 276 TABLE 286 AUSTRALIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 276 TABLE 287 AUSTRALIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 276 TABLE 288 AUSTRALIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 277 TABLE 289 AUSTRALIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024–2031 (USD MILLION) 277 TABLE 290 AUSTRALIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024–2031 (USD MILLION) 277 TABLE 291 AUSTRALIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024–2031 (USD MILLION) 278 TABLE 292 AUSTRALIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION) 278 TABLE 293 AUSTRALIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 278 TABLE 294 AUSTRALIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 279 TABLE 295 AUSTRALIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 279 TABLE 296 AUSTRALIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024–2031 (USD MILLION) 279 TABLE 297 SOUTH KOREA: KEY MACROINDICATORS 280 TABLE 298 SOUTH KOREA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024–2031 (USD MILLION) 281 TABLE 299 SOUTH KOREA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 281 TABLE 300 SOUTH KOREA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 281 TABLE 301 SOUTH KOREA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 282 TABLE 302 SOUTH KOREA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024–2031 (USD MILLION) 282 TABLE 303 SOUTH KOREA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024–2031 (USD MILLION) 282 TABLE 304 SOUTH KOREA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024–2031 (USD MILLION) 283 TABLE 305 SOUTH KOREA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION) 283 TABLE 306 SOUTH KOREA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 283 TABLE 307 SOUTH KOREA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 284 TABLE 308 SOUTH KOREA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 284 TABLE 309 SOUTH KOREA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024–2031 (USD MILLION) 285 TABLE 310 THAILAND: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024–2031 (USD MILLION) 286 TABLE 311 THAILAND: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 286 TABLE 312 THAILAND: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 286 TABLE 313 THAILAND: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 287 TABLE 314 THAILAND: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024–2031 (USD MILLION) 287 TABLE 315 THAILAND: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024–2031 (USD MILLION) 287 TABLE 316 THAILAND: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024–2031 (USD MILLION) 288 TABLE 317 THAILAND: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION) 288 TABLE 318 THAILAND: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 288 TABLE 319 THAILAND: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 289 TABLE 320 THAILAND: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 289 TABLE 321 THAILAND: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024–2031 (USD MILLION) 289 TABLE 322 NEW ZEALAND: KEY MACROINDICATORS 290 TABLE 323 NEW ZEALAND: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024–2031 (USD MILLION) 291 TABLE 324 NEW ZEALAND: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 291 TABLE 325 NEW ZEALAND: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 291 TABLE 326 NEW ZEALAND: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 292 TABLE 327 NEW ZEALAND: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024–2031 (USD MILLION) 292 TABLE 328 NEW ZEALAND: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024–2031 (USD MILLION) 292 TABLE 329 NEW ZEALAND: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024–2031 (USD MILLION) 293 TABLE 330 NEW ZEALAND: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION) 293 TABLE 331 NEW ZEALAND: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 293 TABLE 332 NEW ZEALAND: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 294 TABLE 333 NEW ZEALAND: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 294 TABLE 334 NEW ZEALAND: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024–2031 (USD MILLION) 294 TABLE 335 REST OF ASIA PACIFIC: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024–2031 (USD MILLION) 295 TABLE 336 REST OF ASIA PACIFIC: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 295 TABLE 337 REST OF ASIA PACIFIC: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 296 TABLE 338 REST OF ASIA PACIFIC: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 296 TABLE 339 REST OF ASIA PACIFIC: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024–2031 (USD MILLION) 296 TABLE 340 REST OF ASIA PACIFIC: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024–2031 (USD MILLION) 297 TABLE 341 REST OF ASIA PACIFIC: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024–2031 (USD MILLION) 297 TABLE 342 REST OF ASIA PACIFIC: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION) 297 TABLE 343 REST OF ASIA PACIFIC: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 298 TABLE 344 REST OF ASIA PACIFIC: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 298 TABLE 345 REST OF ASIA PACIFIC: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 298 TABLE 346 REST OF ASIA PACIFIC: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024–2031 (USD MILLION) 299 TABLE 347 LATIN AMERICA: SMALL-MOLECULE PHARMACEUTICALS MARKET FOR API/DRUG SUBSTANCES, BY TYPE, 2024–2031 (METRIC TONS) 300 TABLE 348 LATIN AMERICA: SMALL-MOLECULE PHARMACEUTICALS MARKET FOR FILL-FINISH/DRUG PRODUCTS, BY TYPE, 2024–2031 (TEN THOUSAND UNITS) 300 TABLE 349 LATIN AMERICA: ANIMAL HEALTH BIOLOGICS & VACCINES MARKET FOR API/DRUG SUBSTANCES, BY TYPE, 2024–2031 (METRIC TONS) 300 TABLE 350 LATIN AMERICA: ANIMAL HEALTH BIOLOGICS & VACCINES MARKET FOR FILL-FINISH/DRUG PRODUCTS, BY TYPE, 2024–2031 (THOUSAND UNITS) 301 TABLE 351 LATIN AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 301 TABLE 352 LATIN AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024–2031 (USD MILLION) 301 TABLE 353 LATIN AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 302 TABLE 354 LATIN AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 302 TABLE 355 LATIN AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 302 TABLE 356 LATIN AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024–2031 (USD MILLION) 303 TABLE 357 LATIN AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024–2031 (USD MILLION) 303 TABLE 358 LATIN AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024–2031 (USD MILLION) 303 TABLE 359 LATIN AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION) 304 TABLE 360 LATIN AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 304 TABLE 361 LATIN AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 304 TABLE 362 LATIN AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 305 TABLE 363 LATIN AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024–2031 (USD MILLION) 305 TABLE 364 BRAZIL: KEY MACROINDICATORS 306 TABLE 365 BRAZIL: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024–2031 (USD MILLION) 306 TABLE 366 BRAZIL: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 307 TABLE 367 BRAZIL: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 307 TABLE 368 BRAZIL: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 307 TABLE 369 BRAZIL: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024–2031 (USD MILLION) 308 TABLE 370 BRAZIL: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024–2031 (USD MILLION) 308 TABLE 371 BRAZIL: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024–2031 (USD MILLION) 308 TABLE 372 BRAZIL: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION) 309 TABLE 373 BRAZIL: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 309 TABLE 374 BRAZIL: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 309 TABLE 375 BRAZIL: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 310 TABLE 376 BRAZIL: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024–2031 (USD MILLION) 310 TABLE 377 MEXICO: KEY MACROINDICATORS 311 TABLE 378 MEXICO: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024–2031 (USD MILLION) 311 TABLE 379 MEXICO: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 312 TABLE 380 MEXICO: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 312 TABLE 381 MEXICO: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 312 TABLE 382 MEXICO: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024–2031 (USD MILLION) 313 TABLE 383 MEXICO: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024–2031 (USD MILLION) 313 TABLE 384 MEXICO: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024–2031 (USD MILLION) 313 TABLE 385 MEXICO: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION) 314 TABLE 386 MEXICO: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 314 TABLE 387 MEXICO: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 314 TABLE 388 MEXICO: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 315 TABLE 389 MEXICO: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024–2031 (USD MILLION) 315 TABLE 390 ARGENTINA: KEY MACROINDICATORS 316 TABLE 391 ARGENTINA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024–2031 (USD MILLION) 316 TABLE 392 ARGENTINA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 317 TABLE 393 ARGENTINA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 317 TABLE 394 ARGENTINA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 317 TABLE 395 ARGENTINA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024–2031 (USD MILLION) 318 TABLE 396 ARGENTINA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024–2031 (USD MILLION) 318 TABLE 397 ARGENTINA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024–2031 (USD MILLION) 318 TABLE 398 ARGENTINA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION) 319 TABLE 399 ARGENTINA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 319 TABLE 400 ARGENTINA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 319 TABLE 401 ARGENTINA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 320 TABLE 402 ARGENTINA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024–2031 (USD MILLION) 320 TABLE 403 REST OF LATIN AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024–2031 (USD MILLION) 321 TABLE 404 REST OF LATIN AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 321 TABLE 405 REST OF LATIN AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 322 TABLE 406 REST OF LATIN AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 322 TABLE 407 REST OF LATIN AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024–2031 (USD MILLION) 322 TABLE 408 REST OF LATIN AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024–2031 (USD MILLION) 323 TABLE 409 REST OF LATIN AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024–2031 (USD MILLION) 323 TABLE 410 REST OF LATIN AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION) 323 TABLE 411 REST OF LATIN AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 324 TABLE 412 REST OF LATIN AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 324 TABLE 413 REST OF LATIN AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 324 TABLE 414 REST OF LATIN AMERICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024–2031 (USD MILLION) 325 TABLE 415 MIDDLE EAST & AFRICA: SMALL-MOLECULE PHARMACEUTICALS MARKET FOR API/DRUG SUBSTANCES, BY TYPE, 2024–2031 (METRIC TONS) 326 TABLE 416 MIDDLE EAST & AFRICA: SMALL-MOLECULE PHARMACEUTICALS MARKET FOR FILL-FINISH/DRUG PRODUCTS, BY TYPE, 2024–2031 (TEN THOUSAND UNITS) 326 TABLE 417 MIDDLE EAST & AFRICA: ANIMAL HEALTH BIOLOGICS & VACCINES MARKET FOR API/DRUG SUBSTANCES, BY TYPE, 2024–2031 (METRIC TONS) 326 TABLE 418 MIDDLE EAST & AFRICA: ANIMAL HEALTH BIOLOGICS & VACCINES MARKET FOR FILL-FINISH/DRUG PRODUCTS, BY TYPE, 2024–2031 (THOUSAND UNITS) 327 TABLE 419 MIDDLE EAST & AFRICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY REGION, 2024–2031 (USD MILLION) 327 TABLE 420 MIDDLE EAST & AFRICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024–2031 (USD MILLION) 327 TABLE 421 MIDDLE EAST & AFRICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 328 TABLE 422 MIDDLE EAST & AFRICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 328 TABLE 423 MIDDLE EAST & AFRICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 328 TABLE 424 MIDDLE EAST & AFRICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024–2031 (USD MILLION) 329 TABLE 425 MIDDLE EAST & AFRICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024–2031 (USD MILLION) 329 TABLE 426 MIDDLE EAST & AFRICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024–2031 (USD MILLION) 329 TABLE 427 MIDDLE EAST & AFRICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION) 330 TABLE 428 MIDDLE EAST & AFRICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 330 TABLE 429 MIDDLE EAST & AFRICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 330 TABLE 430 MIDDLE EAST & AFRICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 331 TABLE 431 MIDDLE EAST & AFRICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024–2031 (USD MILLION) 331 TABLE 432 GCC COUNTRIES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 332 TABLE 433 GCC COUNTRIES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024–2031 (USD MILLION) 332 TABLE 434 GCC COUNTRIES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 332 TABLE 435 GCC COUNTRIES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 333 TABLE 436 GCC COUNTRIES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 333 TABLE 437 GCC COUNTRIES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024–2031 (USD MILLION) 333 TABLE 438 GCC COUNTRIES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024–2031 (USD MILLION) 334 TABLE 439 GCC COUNTRIES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024–2031 (USD MILLION) 334 TABLE 440 GCC COUNTRIES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION) 334 TABLE 441 GCC COUNTRIES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 335 TABLE 442 GCC COUNTRIES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 335 TABLE 443 GCC COUNTRIES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 335 TABLE 444 GCC COUNTRIES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024–2031 (USD MILLION) 336 TABLE 445 KINGDOM OF SAUDI ARABIA: KEY MACROINDICATORS 337 TABLE 446 KINGDOM OF SAUDI ARABIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024–2031 (USD MILLION) 337 TABLE 447 KINGDOM OF SAUDI ARABIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 337 TABLE 448 KINGDOM OF SAUDI ARABIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 338 TABLE 449 KINGDOM OF SAUDI ARABIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 338 TABLE 450 KINGDOM OF SAUDI ARABIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024–2031 (USD MILLION) 338 TABLE 451 KINGDOM OF SAUDI ARABIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024–2031 (USD MILLION) 339 TABLE 452 KINGDOM OF SAUDI ARABIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024–2031 (USD MILLION) 339 TABLE 453 KINGDOM OF SAUDI ARABIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION) 339 TABLE 454 KINGDOM OF SAUDI ARABIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 340 TABLE 455 KINGDOM OF SAUDI ARABIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 340 TABLE 456 KINGDOM OF SAUDI ARABIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 340 TABLE 457 KINGDOM OF SAUDI ARABIA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024–2031 (USD MILLION) 341 TABLE 458 UNITED ARAB EMIRATES: KEY MACROINDICATORS 342 TABLE 459 UNITED ARAB EMIRATES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024–2031 (USD MILLION) 342 TABLE 460 UNITED ARAB EMIRATES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 342 TABLE 461 UNITED ARAB EMIRATES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 343 TABLE 462 UNITED ARAB EMIRATES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 343 TABLE 463 UNITED ARAB EMIRATES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024–2031 (USD MILLION) 343 TABLE 464 UNITED ARAB EMIRATES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024–2031 (USD MILLION) 344 TABLE 465 UNITED ARAB EMIRATES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024–2031 (USD MILLION) 344 TABLE 466 UNITED ARAB EMIRATES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION) 344 TABLE 467 UNITED ARAB EMIRATES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 345 TABLE 468 UNITED ARAB EMIRATES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 345 TABLE 469 UNITED ARAB EMIRATES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 345 TABLE 470 UNITED ARAB EMIRATES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024–2031 (USD MILLION) 346 TABLE 471 REST OF GCC COUNTRIES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024–2031 (USD MILLION) 346 TABLE 472 REST OF GCC COUNTRIES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 347 TABLE 473 REST OF GCC COUNTRIES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 347 TABLE 474 REST OF GCC COUNTRIES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 347 TABLE 475 REST OF GCC COUNTRIES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024–2031 (USD MILLION) 348 TABLE 476 REST OF GCC COUNTRIES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024–2031 (USD MILLION) 348 TABLE 477 REST OF GCC COUNTRIES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024–2031 (USD MILLION) 348 TABLE 478 REST OF GCC COUNTRIES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION) 349 TABLE 479 REST OF GCC COUNTRIES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 349 TABLE 480 REST OF GCC COUNTRIES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 349 TABLE 481 REST OF GCC COUNTRIES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 350 TABLE 482 REST OF GCC COUNTRIES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024–2031 (USD MILLION) 350 TABLE 483 REST OF MIDDLE EAST & AFRICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2024–2031 (USD MILLION) 351 TABLE 484 REST OF MIDDLE EAST & AFRICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 351 TABLE 485 REST OF MIDDLE EAST & AFRICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2024–2031 (USD MILLION) 351 TABLE 486 REST OF MIDDLE EAST & AFRICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2024–2031 (USD MILLION) 352 TABLE 487 REST OF MIDDLE EAST & AFRICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICINES, BY TYPE, 2024–2031 (USD MILLION) 352 TABLE 488 REST OF MIDDLE EAST & AFRICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR SMALL-MOLECULE PHARMACEUTICALS, BY TYPE, 2024–2031 (USD MILLION) 352 TABLE 489 REST OF MIDDLE EAST & AFRICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR ANIMAL HEALTH BIOLOGICS & VACCINES, BY TYPE, 2024–2031 (USD MILLION) 353 TABLE 490 REST OF MIDDLE EAST & AFRICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR MEDICAL DEVICES, BY TYPE, 2024–2031 (USD MILLION) 353 TABLE 491 REST OF MIDDLE EAST & AFRICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION) 353 TABLE 492 REST OF MIDDLE EAST & AFRICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 354 TABLE 493 REST OF MIDDLE EAST & AFRICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION) 354 TABLE 494 REST OF MIDDLE EAST & AFRICA: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024–2031 (USD MILLION) 355 TABLE 495 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET 356 TABLE 496 VETERINARY CONTRACT RESEARCH ORGANIZATIONS MARKET: DEGREE OF COMPETITION 360 TABLE 497 VETERINARY CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS MARKET: DEGREE OF COMPETITION 364 TABLE 498 VETERINARY CRO MARKET: REGION FOOTPRINT 369 TABLE 499 VETERINARY CRO MARKET: SERVICE FOOTPRINT 370 TABLE 500 VETERINARY CRO MARKET: PRODUCT TYPE FOOTPRINT 371 TABLE 501 VETERINARY CRO MARKET: ANIMAL TYPE FOOTPRINT 371 TABLE 502 VETERINARY CRO MARKET: DETAILED LIST OF KEY VETERINARY CRO STARTUPS/SMES 374 TABLE 503 VETERINARY CRO MARKET: COMPETITIVE BENCHMARKING OF KEY VETERINARY CRO STARTUPS/SMES 375 TABLE 504 VETERINARY CDMO MARKET: REGION FOOTPRINT 378 TABLE 505 VETERINARY CDMO MARKET: SERVICE FOOTPRINT 379 TABLE 506 VETERINARY CDMO MARKET: PRODUCT TYPE FOOTPRINT 380 TABLE 507 VETERINARY CDMO MARKET: ANIMAL TYPE FOOTPRINT 380 TABLE 508 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET: DETAILED LIST OF KEY VETERINARY CDMO STARTUPS/SMES 383 TABLE 509 VETERINARY CDMO MARKET: COMPETITIVE BENCHMARKING OF KEY VETERINARY CDMO STARTUPS/SMES 384 TABLE 510 VETERINARY CDMO & CRO MARKET: SERVICE LAUNCHES & APPROVALS, JANUARY 2022−NOVEMBER 2025 387 TABLE 511 VETERINARY CDMO & CRO MARKET: DEALS, JANUARY 2022−NOVEMBER 2025 388 TABLE 512 VETERINARY CDMO & CRO MARKET: EXPANSIONS, JANUARY 2022−NOVEMBER 2025 389 TABLE 513 VETERINARY CDMO & CRO MARKET: OTHER DEVELOPMENTS, JANUARY 2022-NOVEMBER 2025 390 TABLE 514 ARGENTA HOLDCO LIMITED: COMPANY OVERVIEW 392 TABLE 515 ARGENTA HOLDCO LIMITED: SERVICES OFFERED 393 TABLE 516 ARGENTA HOLDCO LIMITED: SERVICE LAUNCHES & UPGRADES, JANUARY 2022−NOVEMBER 2025 394 TABLE 517 ARGENTA HOLDCO LIMITED: DEALS, JANUARY 2022–NOVEMBER 2025 394 TABLE 518 ARGENTA HOLDCO LIMITED: EXPANSIONS, JANUARY 2022–NOVEMBER 2025 395 TABLE 519 AENOVA GROUP: COMPANY OVERVIEW 397 TABLE 520 AENOVA GROUP: SERVICES OFFERED 398 TABLE 521 AENOVA GROUP: EXPANSIONS, JANUARY 2022–NOVEMBER 2025 399 TABLE 522 AENOVA GROUP: OTHER DEVELOPMENTS, JANUARY 2022−NOVEMBER 2025 401 TABLE 523 FAREVA SA: COMPANY OVERVIEW 403 TABLE 524 FAREVA SA: SERVICES OFFERED 404 TABLE 525 VETIO: COMPANY OVERVIEW 406 TABLE 526 VETIO: SERVICES OFFERED 406 TABLE 527 TRIRX PHARMACEUTICAL SERVICES: COMPANY OVERVIEW 409 TABLE 528 TRIRX PHARMACEUTICAL SERVICES: SERVICES OFFERED 409 TABLE 529 INDIAN IMMUNOLOGICALS LTD.: COMPANY OVERVIEW 412 TABLE 530 INDIAN IMMUNOLOGICALS LTD.: SERVICES OFFERED 412 TABLE 531 RECIPHARM AB: COMPANY OVERVIEW 413 TABLE 532 RECIPHARM AB: SERVICES OFFERED 413 TABLE 533 RECIPHARM AB: TECHNOLOGY LAUNCHES, JANUARY 2022−NOVEMBER 2025 414 TABLE 534 RECIPHARM AB: DEALS, JANUARY 2022−NOVEMBER 2025 415 TABLE 535 RECIPHARM AB: EXPANSIONS, JANUARY 2022–NOVEMBER 2025 415 TABLE 536 RECIPHARM AB: OTHER DEVELOPMENTS, JANUARY 2022−NOVEMBER 2025 417 TABLE 537 LABIANA: COMPANY OVERVIEW 418 TABLE 538 LABIANA: SERVICES OFFERED 419 TABLE 539 LABIANA: OTHER DEVELOPMENTS, JANUARY 2022−NOVEMBER 2025 420 TABLE 540 SYNGENE INTERNATIONAL LIMITED: COMPANY OVERVIEW 421 TABLE 541 SYNGENE INTERNATIONAL LIMITED: SERVICES OFFERED 422 TABLE 542 SYNGENE INTERNATIONAL LIMITED: DEALS, JANUARY 2022−NOVEMBER 2025 424 TABLE 543 SYNGENE INTERNATIONAL LIMITED: OTHER DEVELOPMENTS, JANUARY 2022−NOVEMBER 2025 425 TABLE 544 CZ VACCINES: COMPANY OVERVIEW 426 TABLE 545 CZ VACCINES: SERVICES OFFERED 427 TABLE 546 AB7 GROUP: COMPANY OVERVIEW 428 TABLE 547 KELA HEALTH: COMPANY OVERVIEW 429 TABLE 548 EIRGEN PHARMA: COMPANY OVERVIEW 430 TABLE 549 BIOINGENIUM: COMPANY OVERVIEW 431 TABLE 550 ELISE BIOPHARMA: COMPANY OVERVIEW 432 TABLE 551 LABCORP: COMPANY OVERVIEW 433 TABLE 552 LABCORP: SERVICES OFFERED 434 TABLE 553 LABCORP: TECHNOLOGY LAUNCHES, JANUARY 2022−NOVEMBER 2025 435 TABLE 554 LABCORP: EXPANSIONS, JANUARY 2022–NOVEMBER 2025 435 TABLE 555 EUROFINS SCIENTIFIC: COMPANY OVERVIEW 437 TABLE 556 EUROFINS SCIENTIFIC: SERVICES OFFERED 438 TABLE 557 EUROFINS SCIENTIFIC: DEALS, JANUARY 2022–NOVEMBER 2025 439 TABLE 558 CHARLES RIVER LABORATORIES: COMPANY OVERVIEW 441 TABLE 559 CHARLES RIVER LABORATORIES: SERVICES OFFERED 442 TABLE 560 KNOELL GERMANY GMBH: COMPANY OVERVIEW 445 TABLE 561 KNOELL GERMANY GMBH: SERVICES OFFERED 445 TABLE 562 KNOELL GERMANY GMBH: DEALS, JANUARY 2022–NOVEMBER 2025 447 TABLE 563 KNOELL GERMANY GMBH: OTHER DEVELOPMENTS, JANUARY 2022−NOVEMBER 2025 447 TABLE 564 EVOTEC: COMPANY OVERVIEW 449 TABLE 565 EVOTEC: SERVICES OFFERED 450 TABLE 566 EVOTEC: DEALS, JANUARY 2022−NOVEMBER 2025 451 TABLE 567 KLIFOVET GMBH: COMPANY OVERVIEW 453 TABLE 568 KLIFOVET GMBH: SERVICES OFFERED 454 TABLE 569 CLINGLOBAL: COMPANY OVERVIEW 456 TABLE 570 CLINGLOBAL: SERVICES OFFERED 456 TABLE 571 CLINGLOBAL: SERVICE LAUNCHES, JANUARY 2022−NOVEMBER 2025 457 TABLE 572 CLINGLOBAL: DEALS, JANUARY 2022–NOVEMBER 2025 458 TABLE 573 CLINGLOBAL: OTHER DEVELOPMENTS, JANUARY 2022−NOVEMBER 2025 459 TABLE 574 BIOAGILE THERAPEUTICS PRIVATE LIMITED: COMPANY OVERVIEW 460 TABLE 575 BIOAGILE THERAPEUTICS PRIVATE LIMITED: SERVICES OFFERED 460 TABLE 576 VETSPIN SRL: COMPANY OVERVIEW 462 TABLE 577 VETSPIN SRL: SERVICES OFFERED 462 TABLE 578 VETERINARY RESEARCH MANAGEMENT: COMPANY OVERVIEW 464 TABLE 579 VETERINARY RESEARCH MANAGEMENT: SERVICES OFFERED 464 TABLE 580 RIDGEWAY RESEARCH LTD.: COMPANY OVERVIEW 466 TABLE 581 LÖHLEIN AND WOLF VET RESEARCH: COMPANY OVERVIEW 467 TABLE 582 CEBIPHAR: COMPANY OVERVIEW 468 TABLE 583 OCRVET: COMPANY OVERVIEW 469 TABLE 584 EAST TENNESSEE CLINICAL RESEARCH, INC.: COMPANY OVERVIEW 470 TABLE 585 RISK ASSESSMENT ANALYSIS 487 FIGURE 1 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET SEGMENTATION & REGIONAL SCOPE 45 FIGURE 2 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY SERVICE, 2026 VS. 2031 (USD MILLION) 49 FIGURE 3 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CRO SERVICES, BY TYPE, 2026 VS. 2031 (USD MILLION) 50 FIGURE 4 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET FOR CDMO SERVICES, BY TYPE, 2026 VS. 2031 (USD MILLION) 51 FIGURE 5 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY PRODUCT TYPE, 2026 VS. 2031 (USD MILLION) 51 FIGURE 6 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY ANIMAL TYPE, 2026 VS. 2031 (USD MILLION) 52 FIGURE 7 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2026 VS. 2031 (USD MILLION) 53 FIGURE 8 GEOGRAPHIC SNAPSHOT OF VETERINARY CROS MARKET 54 FIGURE 9 GEOGRAPHIC SNAPSHOT OF VETERINARY CDMOS MARKET 55 FIGURE 10 ADVANCEMENTS IN VETERINARY BIOLOGICS TO FUEL MARKET GROWTH 56 FIGURE 11 CDMO SERVICES SEGMENT IN CHINA ACCOUNTED FOR LARGEST MARKET SHARE IN 2024 57 FIGURE 12 ASIA PACIFIC TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 58 FIGURE 13 ASIA PACIFIC TO RECORD HIGHEST CAGR DURING FORECAST PERIOD 58 FIGURE 14 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 59 FIGURE 15 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD 60 FIGURE 16 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 61 FIGURE 17 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET: PORTER'S FIVE FORCES ANALYSIS 72 FIGURE 18 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET: SUPPLY CHAIN ANALYSIS 77 FIGURE 19 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET: VALUE CHAIN ANALYSIS 79 FIGURE 20 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET: ECOSYSTEM ANALYSIS 80 FIGURE 21 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 85 FIGURE 22 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET: INVESTMENT & FUNDING SCENARIO 86 FIGURE 23 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET: NUMBER OF GRANTED PATENT APPLICATIONS (JANUARY 2014–NOVEMBER 2025) 92 FIGURE 24 TOP APPLICANT COUNTRIES/REGIONS FOR VETERINARY PHARMACEUTICAL PATENTS (JANUARY 2014–NOVEMBER 2025) 93 FIGURE 25 AI USE CASES 97 FIGURE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VETERINARY CDMOS & CROS 104 FIGURE 27 KEY BUYING CRITERIA FOR TOP THREE END USERS 105 FIGURE 28 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET: GEOGRAPHIC SNAPSHOT 191 FIGURE 29 EUROPE: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET SNAPSHOT 210 FIGURE 30 ASIA PACIFIC: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET SNAPSHOT 253 FIGURE 31 REVENUE ANALYSIS OF KEY PLAYERS IN VETERINARY CROS MARKET, 2021−2025 358 FIGURE 32 REVENUE ANALYSIS OF KEY PLAYERS IN VETERINARY CDMOS MARKET, 2021−2025 359 FIGURE 33 GLOBAL MARKET SHARE ANALYSIS OF VETERINARY CONTRACT RESEARCH ORGANIZATIONS, 2025 360 FIGURE 34 RANKING OF VETERINARY CONTRACT RESEARCH ORGANIZATIONS, 2025 361 FIGURE 35 US MARKET SHARE ANALYSIS OF VETERINARY CONTRACT RESEARCH ORGANIZATIONS (2025) 362 FIGURE 36 EUROPE MARKET SHARE ANALYSIS OF VETERINARY CONTRACT RESEARCH ORGANIZATIONS (2025) 363 FIGURE 37 GLOBAL MARKET SHARE ANALYSIS OF VETERINARY CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS, 2025 364 FIGURE 38 RANKING OF VETERINARY CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS, 2025 365 FIGURE 39 US MARKET SHARE ANALYSIS OF VETERINARY CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS (2025) 366 FIGURE 40 EUROPE MARKET SHARE ANALYSIS OF VETERINARY CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS (2025) 367 FIGURE 41 VETERINARY CRO MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025 368 FIGURE 42 VETERINARY CRO MARKET: COMPANY FOOTPRINT 369 FIGURE 43 VETERINARY CRO MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 373 FIGURE 44 VETERINARY CDMO MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025 377 FIGURE 45 VETERINARY CONTRACT CDMO MARKET: COMPANY FOOTPRINT 378 FIGURE 46 VETERINARY CDMO MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 382 FIGURE 47 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET: SERVICE COMPARATIVE ANALYSIS 385 FIGURE 48 EV/EBITDA OF KEY VENDORS 386 FIGURE 49 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 386 FIGURE 50 AENOVA GROUP: COMPANY SNAPSHOT (2024) 398 FIGURE 51 LABIANA: COMPANY SNAPSHOT (2024) 419 FIGURE 52 SYNGENE INTERNATIONAL LIMITED: COMPANY SNAPSHOT (2025) 422 FIGURE 53 LABCORP: COMPANY SNAPSHOT (2024) 434 FIGURE 54 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2024) 438 FIGURE 55 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2024) 442 FIGURE 56 EVOTEC: COMPANY SNAPSHOT (2024) 450 FIGURE 57 VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET: RESEARCH DESIGN 471 FIGURE 58 PRIMARY SOURCES 473 FIGURE 59 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION (SUPPLY SIDE) 476 FIGURE 60 BREAKDOWN OF PRIMARY INTERVIEWS: BY END USER, DESIGNATION, AND REGION (DEMAND SIDE) 476 FIGURE 61 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 477 FIGURE 62 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 478 FIGURE 63 REVENUE SHARE ANALYSIS ILLUSTRATION: CHARLES RIVER LABORATORIES 478 FIGURE 64 REVENUE ANALYSIS OF TOP FIVE COMPANIES: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET (2025) 479 FIGURE 65 DEMAND-SIDE MARKET ESTIMATION FOR VETERINARY CRO SERVICES 480 FIGURE 66 DEMAND-SIDE MARKET ESTIMATION FOR VETERINARY CDMO SERVICES 481 FIGURE 67 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET (2026–2031) 482 FIGURE 68 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 482 FIGURE 69 TOP-DOWN APPROACH 483 FIGURE 70 BOTTOM-UP APPROACH 484 FIGURE 71 MARKET DATA TRIANGULATION METHODOLOGY 485

同分類最新報告（醫療器材）

查看醫療器材全部報告 →

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們